UBE2V2P2

Across TCGA pan-cancer cohorts, UBE2V2P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of UBE2V2P2’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where UBE2V2P2 RNA is repressed in tumor relative to normal tissue. In most cancer types UBE2V2P2 is over-expressed in tumor, although a few such as ESCA and KIRC show the opposite, repressed pattern.

ESCA, LUSC, and KIRC are the cancer types where UBE2V2P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2V2P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	All	−0.100	.017	2	view →
LUSC	Male	All	+0.036	.022	1	view →
KIRC	All	III,IV	−0.010	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

UBE2V2P2–ESCA

Open the ESCA breakdown →